Moderna: As the commercial team strengthens the foundation of the seasonal vaccine business, we are targeting an estimated revenue range of $1.6 billion to $2 billion.

Moderna: As the commercial team strengthens the foundation of the seasonal vaccine business, we are targeting an estimated revenue range of $1.6 billion to $2 billion.